Synaffix Wins World ADC Award for Poster on Efficacy and Tolerability Data on SYNtecan E™-Based ADCs

/PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug...

Related Keywords

Netherlands ,Amsterdam ,Noord Holland ,Innovent Biologics ,Prnewswire Synaffix ,Hanson Wade ,Exatecan Syntecan ,Platform Technology ,Best Poster ,Show Excellent In Vivo Efficacy ,Mersana Therapeutics ,Shanghai Miracogen ,Biogeneration Ventures ,Both Glycoconnect ,Synaffix ,